Compare VERA & BBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VERA | BBT |
|---|---|---|
| Founded | 2016 | 1846 |
| Country | United States | United States |
| Employees | N/A | 2050 |
| Industry | Biotechnology: Pharmaceutical Preparations | Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2B | 2.7B |
| IPO Year | 2021 | N/A |
| Metric | VERA | BBT |
|---|---|---|
| Price | $43.21 | $31.68 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 4 |
| Target Price | ★ $81.30 | $33.25 |
| AVG Volume (30 Days) | ★ 1.1M | 684.4K |
| Earning Date | 05-05-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 4.07% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $77.88 |
| Revenue Next Year | $472.48 | $4.31 |
| P/E Ratio | ★ N/A | $29.98 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $18.76 | $22.81 |
| 52 Week High | $56.05 | $32.32 |
| Indicator | VERA | BBT |
|---|---|---|
| Relative Strength Index (RSI) | 57.02 | 64.65 |
| Support Level | $37.54 | $29.17 |
| Resistance Level | $56.05 | $31.98 |
| Average True Range (ATR) | 2.32 | 0.65 |
| MACD | 0.55 | 0.19 |
| Stochastic Oscillator | 59.29 | 80.87 |
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.
Beacon Financial Corp operates as a multi-bank holding company. It offers commercial, business, and retail banking services, including a full complement of cash management products, online banking services, and consumer and residential loans.